FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2000976450> ?p ?o ?g. }

• W2000976450 endingPage "865" @default.
• W2000976450 startingPage "863" @default.
• W2000976450 abstract "Nitric oxide (NO), a major free radical, is an important signalling molecule in the cardiovascular system. It influences vascular function through its vasodilatory, anti-growth and anti-inflammatory properties [1]. In addition, NO modulates other important aspects of vascular function, including leukocyte activation, platelet aggregation and interactions between the endothelium and circulating cells [2,3]. Thus, NO, which signals through cGMP-dependent and cGMP-independent pathways [4], plays a major role in maintaining vascular integrity and homeostasis. Because of its importance in the vasculature, NO production and metabolism must be tightly regulated. Three genes encoding three different nitric oxide synthases (NOS) are responsible for enzymatic generation of NO from l-arginine, including endothelial NOS (eNOS), inducible NOS (iNOS) and neuronal NOS (nNOS) [5,6]. eNOS, found mainly in the endothelium, and nNOS, located primarily in vascular smooth muscle cells, are Ca2+/calmodulin-dependent and are constitutively expressed [7,8]. iNOS is ubiquitous, Ca2+/calmodulin-independent and induced by cytokines, vasoactive agents and endotoxin [9]. Fluid shear stress and pulsatile stretch are major stimuli for eNOS activity, and have been implicated to play an important role in basal production of vascular NO [6–8,10]. Until recently, the role of nNOS and factors regulating its expression and activity in arteries were unclear. In this issue of the journal, Ebrahimian et al. [11] shed light on putative mechanisms that modulate vascular nNOS. In isolated rat carotid arteries exposed for 24 h to high intraluminal pressure, nNOS expression was markedly increased. This was evident both in the absence and the presence of endothelium and adventitia, indicating that vascular nNOS is located primarily in vascular smooth muscle cells of the media. Using pharmacological inhibitors, it was demonstrated that transmural pressure-induced expression of non-endothelial nNOS was dependent on a functionally active ERK1/2 cascade but independent of endogenous activation of the local renin–angiotensin II system. These findings certainly contribute to our understanding of vascular nNOS regulation, but what do they mean from a functional point of view? The major reason for investigating effects of high intraluminal pressure in intact arteries was to simulate as close as possible the situation in hypertension. To achieve this, isolated arteries were mounted in an organ culture system for 24 h and intraluminal pressure was increased to levels as high as 200 mmHg [11]. Previous studies showed that high intraluminal pressure in hypertension is associated with dysfunctional NO generation due, in part, to altered expression and activation of NOS [12,13]. Studies from NOS knockout mice, gene transfer and transgenic models, experimental models of hypertension, as well as human hypertension, demonstrate that vascular NO bioavailability is reduced [14–16]. This relative NO deficiency leads to vasoconstriction, leukocyte activation, increased vascular smooth muscle cell proliferation, inflammation and increased propensity to thrombosis [13,17]. How then can increased expression of NOS and enhanced NO generation induced by increased intraluminal pressure, as shown in the study of Ebrahimian et al. [11], be reconciled with reduced NO bioavailability in hypertension? The answer to this paradox may lie in the enzymatic source of NO production. Over-expression of nNOS with resultant increased vascular smooth muscle cell NO bioactivity induced by high intraluminal pressure contributes to vascular smooth muscle relaxation. This is demonstrated indirectly in the study by Ebrahimian et al. [11], as preferential inhibition of nNOS with S-methyl-l-thiocitrulline significantly enhanced contractile responses to angiotensin II in pressurized arteries. In hypertension, where intraluminal pressure is increased, augmented nNOS-derived NO may offset decreased eNOS-derived NO, thereby acting as an adaptive mechanism. Overerexpression of nNOS has been demonstrated in vascular smooth muscle cells and resistance arteries from hypertensive rats [18,19]. On the other hand, endothelial-derived NO, due to decreased eNOS expression and activity and/or increased quenching by •O2−, is reduced in hypertension [20,21]. The expressional down-regulation of eNOS has been directly implicated in glucocorticoid-induced hypertension [22]. Furthermore, in eNOS knockout mice, endothelium-derived relaxing factor activity is abolished, endothelial function is impaired and mice are hypertensive with mean arterial blood pressure values that are 20–30 mmHg greater than values observed in wild-type counterparts [23]. To further support a role for decreased eNOS activity in hypertension, Xiao et al. [24] reported that circulating endothelial NOS inhibitory factor, which is increased in patients with renal failure and hypertension, inhibits eNOS activity in cultured human endothelial cells. Accordingly, it may be possible that the effects of NO produced by one NOS isoform antagonize the effects of NO produced by another isoform. Pressure-mediated nNOS-derived NO in the presence of blunted eNOS-generated NO may act as a compensatory mechanism to maintain the production of bioactive NO in high pressure situations, such as in hypertension. However, not all models of hypertension exhibit attenuated eNOS activity. By contrast, NO production may be increased in hypertension. Some studies reported increased expression of both eNOS and nNOS in hypertension [25,26]. This occurs in young and aged spontaneously hypertensive rats (SHR), suggesting that development of hypertension may not be due to a primary impairment of NO production in SHR [27]. Furthermore high shear stress itself induces up-regulation of eNOS. Indeed, in the study by Ebrahimian et al. [11], not only was nNOS activity enhanced by pressure, but also eNOS expression was augmented. These phenomena may act to overwhelm increased oxidative stress, a major factor implicated in vascular damage associated with hypertension [28,29]. Unfortunately, this aspect is not addressed in their study [11], and it would have been particularly interesting to know whether increased intraluminal pressure in organ culture preparations does in fact stimulate production of reactive oxygen species. Others have shown that physical factors, such as shear stress, stretch, flow and pressure, are mediators of oxidative stress in hypertensive vessels [30]. Although the study by Ebrahimian et al. [11] contributes to the body of knowledge regarding nNOS regulation, there are a number of limitations that warrant attention. First, an intraluminal pressure of 200 mmHg is very high. It is rare that peripheral resistance arteries, vessels important in blood pressure regulation, would be exposed to such pressures, even in situations of severe and malignant hypertension. Furthermore, the pressure was constant whereas in-vivo intra-arterial pressure is pulsatile and influenced by dynamic extra-arterial pressure fluctuations. Similarly, changes in shear stress, which were not accounted for in the present study, may significantly influence endothelial function and NO production. Accordingly, caution is warrented when extrapolating data from the organ culture system, where carotid arteries from normotensive rats were studied, to in-vivo conditions in hypertension. Second, physical factors, through mechanotransduction signalling pathways, influence many genes and signalling cascades [31]. Of particular interest within the context of the present study is the fact that increased intraluminal pressure up-regulates expression of pre-pro-endothelin-1 gene expression, endothelin-1 production and ETB receptor expression [32,33]. Because of the interdependencies between the endothelin- and NO- systems, it is possible that these are concurrently influenced by an intraluminal pressure of 200 mmHg. It would be interesting to investigate whether there is a differential time course of activation and whether increased nNOS expression is a primary phenomenon in response to increased intraluminal pressure, or whether it is a secondary response to up-regulation of the vascular endothelin system. Finally, the conclusion that pressure increases nNOS expression in an ERK1/2-dependent angiotensin II-independent manner may indeed be true for acute situations, but may not necessarily be the case in chronic conditions. In the study by Ebrahimian et al. [11], the role of ERK1/2 and endogenous angiotensin II were assessed after only 9 h of pressurization. It is unlikely that significant de novo angiotensin II synthesis would occur within this short time period. Without knowing whether angiotensin II concentrations were elevated after pressurization, it is difficult to assess if increased intraluminal pressure maintained in the organ culture system did activate the endogenous renin-angiotensin II system. It is possible that longer periods of pressurization are required to induce production of angiotensin II, which could influence nNOS expression through its effects on ERK1/2 signalling [34]. Indeed, in rats infused with angiotensin II for 3 h, expression of eNOS and nNOS was unchanged [35]. However, after 3 days of infusion, NOS expression was augmented [35]. These findings are in agreement with those of others [36] where it was shown that vascular nNOS expression was enhanced in rats infused with subpressor doses of angiotensin II for 6 days. Nevertheless, the study provides interesting data in an in-vitro model that resembles in-vivo conditions as close as possible. It is now clear that nNOS is located primarily in vascular smooth muscle cells and that it is influenced by pressure, Furthermore, activation of the MEK1/2-ERK1/2 signalling cascade plays an important role in nNOS regulation. Whether these events are adaptive processes to counterbalance increased oxidative stress and upregulation of the endothelin system, or whether overexpression of nNOS is a pathological and maladaptive consequence of increased intraluminal pressure, requires further clarification." @default.
• W2000976450 created "2016-06-24" @default.
• W2000976450 creator A5020577597 @default.
• W2000976450 date "2003-05-01" @default.
• W2000976450 modified "2023-10-01" @default.
• W2000976450 title "Pressure-induced expression of vascular neuronal nitric oxide synthase" @default.
• W2000976450 cites W1549255740 @default.
• W2000976450 cites W1857709346 @default.
• W2000976450 cites W1972798096 @default.
• W2000976450 cites W1974739160 @default.
• W2000976450 cites W1985991573 @default.
• W2000976450 cites W1993299109 @default.
• W2000976450 cites W2003465691 @default.
• W2000976450 cites W2031614618 @default.
• W2000976450 cites W2038527687 @default.
• W2000976450 cites W2055852663 @default.
• W2000976450 cites W2057318529 @default.
• W2000976450 cites W2062900999 @default.
• W2000976450 cites W2068139611 @default.
• W2000976450 cites W2078737032 @default.
• W2000976450 cites W2091193879 @default.
• W2000976450 cites W2093217834 @default.
• W2000976450 cites W2096043946 @default.
• W2000976450 cites W2104551305 @default.
• W2000976450 cites W2105767342 @default.
• W2000976450 cites W2115423520 @default.
• W2000976450 cites W2133040336 @default.
• W2000976450 cites W2134244928 @default.
• W2000976450 cites W2134382614 @default.
• W2000976450 cites W2137952781 @default.
• W2000976450 cites W2138088212 @default.
• W2000976450 cites W2147912778 @default.
• W2000976450 cites W2151856560 @default.
• W2000976450 cites W2151915722 @default.
• W2000976450 cites W2155951706 @default.
• W2000976450 cites W2168038844 @default.
• W2000976450 cites W2169182236 @default.
• W2000976450 cites W2320410254 @default.
• W2000976450 cites W2327594763 @default.
• W2000976450 cites W2329685731 @default.
• W2000976450 doi "https://doi.org/10.1097/00004872-200305000-00006" @default.
• W2000976450 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/12714856" @default.
• W2000976450 hasPublicationYear "2003" @default.
• W2000976450 type Work @default.
• W2000976450 sameAs 2000976450 @default.
• W2000976450 citedByCount "2" @default.
• W2000976450 countsByYear W20009764502021 @default.
• W2000976450 crossrefType "journal-article" @default.
• W2000976450 hasAuthorship W2000976450A5020577597 @default.
• W2000976450 hasBestOaLocation W20009764501 @default.
• W2000976450 hasConcept C112243037 @default.
• W2000976450 hasConcept C126322002 @default.
• W2000976450 hasConcept C169760540 @default.
• W2000976450 hasConcept C181199279 @default.
• W2000976450 hasConcept C185592680 @default.
• W2000976450 hasConcept C2777622882 @default.
• W2000976450 hasConcept C2778326061 @default.
• W2000976450 hasConcept C2909202170 @default.
• W2000976450 hasConcept C2992676626 @default.
• W2000976450 hasConcept C519581460 @default.
• W2000976450 hasConcept C55493867 @default.
• W2000976450 hasConcept C71924100 @default.
• W2000976450 hasConcept C86803240 @default.
• W2000976450 hasConcept C95444343 @default.
• W2000976450 hasConcept C98274493 @default.
• W2000976450 hasConceptScore W2000976450C112243037 @default.
• W2000976450 hasConceptScore W2000976450C126322002 @default.
• W2000976450 hasConceptScore W2000976450C169760540 @default.
• W2000976450 hasConceptScore W2000976450C181199279 @default.
• W2000976450 hasConceptScore W2000976450C185592680 @default.
• W2000976450 hasConceptScore W2000976450C2777622882 @default.
• W2000976450 hasConceptScore W2000976450C2778326061 @default.
• W2000976450 hasConceptScore W2000976450C2909202170 @default.
• W2000976450 hasConceptScore W2000976450C2992676626 @default.
• W2000976450 hasConceptScore W2000976450C519581460 @default.
• W2000976450 hasConceptScore W2000976450C55493867 @default.
• W2000976450 hasConceptScore W2000976450C71924100 @default.
• W2000976450 hasConceptScore W2000976450C86803240 @default.
• W2000976450 hasConceptScore W2000976450C95444343 @default.
• W2000976450 hasConceptScore W2000976450C98274493 @default.
• W2000976450 hasIssue "5" @default.
• W2000976450 hasLocation W20009764501 @default.
• W2000976450 hasLocation W20009764502 @default.
• W2000976450 hasLocation W20009764503 @default.
• W2000976450 hasOpenAccess W2000976450 @default.
• W2000976450 hasPrimaryLocation W20009764501 @default.
• W2000976450 hasRelatedWork W1990842025 @default.
• W2000976450 hasRelatedWork W2018797644 @default.
• W2000976450 hasRelatedWork W2120533372 @default.
• W2000976450 hasRelatedWork W2291288583 @default.
• W2000976450 hasRelatedWork W2388981420 @default.
• W2000976450 hasRelatedWork W2487374649 @default.
• W2000976450 hasRelatedWork W2708463025 @default.
• W2000976450 hasRelatedWork W2993443164 @default.
• W2000976450 hasRelatedWork W4313198982 @default.
• W2000976450 hasRelatedWork W2753682715 @default.
• W2000976450 hasVolume "21" @default.
• W2000976450 isParatext "false" @default.

• next